Drug Profile
Iometopane
Alternative Names: 123I β-CIT; Dopascan; GPI-200; RTI-55Latest Information Update: 22 Feb 2018
Price :
$50
*
At a glance
- Originator RTI International
- Developer Daiichi Radioisotope Labs; MGI GP
- Class Radiopharmaceutical diagnostics; Small molecules; Tropanes
- Mechanism of Action Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 28 Oct 2005 Guilford Pharmaceuticals is now called MGI GP
- 05 Oct 2005 Guilford Pharmaceuticals has been acquired by MGI Pharma
- 23 Aug 2005 Schering AG has terminated the license agreement for iometopane